Relief by botulinum toxin of voiding dysfunction due to benign prostatic hyperplasia: results of a randomized, placebo-controlled study

By Maria G.   Brisinda G.   Civello I.M.   Bentivoglio A.R.   Sganga G.   Albanese A.  

Urology, Vol. 62, Iss. 2, 2003-08 ,pp. : 259-264

Elsevier

Access to resources Recommend Favorite

Efficacy of botulinum-a toxin in children with detrusor hyperreflexia due to myelomeningocele: preliminary results

By Schulte-Baukloh H.   Michael T.   Schobert J.   Stolze T.   Knispel H.H.  

Urology, Vol. 59, Iss. 3, 2002-03 ,pp. : 325-327

Elsevier

Access to resources Recommend Favorite

Botulinum Toxin A for Treatment of Neurogenic Detrusor Overactivity and Incontinence in Patients with Spinal Cord Lesions

By Bagi Per   Biering-Sørensen Fin  

Scandinavian Journal of Urology and Nephrology, Vol. 38, Iss. 6, 2004-12 ,pp. : 495-498

Informa Healthcare

Access to resources Recommend Favorite

Botulinum-A Toxin Detrusor Injection as a Novel Approach in the Treatment of Bladder Spasticity in Children with Neurogenic Bladder

By Schulte-Baukloh H.   Michael T.   Sturzebecher B.   Knispel H.H.  

European Urology, Vol. 44, Iss. 1, 2003-07 ,pp. : 139-143

Elsevier

Access to resources Recommend Favorite

Botulinum Toxin as a New Therapy Option for Voiding Disorders: Current State of the Art

By Leippold T.   Reitz A.   Schurch B.  

European Urology, Vol. 44, Iss. 2, 2003-08 ,pp. : 165-174

Elsevier

Access to resources Recommend Favorite